1 / 9

Immunology Market – Trends Forecast Till 2030

The factor responsible for the growth of the global immunology market is the increased funding from various government and non-government organizations. This funding is crucial in ensuring that the necessary resources are available for research and development, as well as for the production and distribution of immunology drugs. On the other hand, the high costs of immunology drugs can be a major obstacle to the growth of the market. Additionally, the adverse effects associated with these drugs can also limit their usage, especially in patients who have other underlying medical conditions.

Delvens1
Download Presentation

Immunology Market – Trends Forecast Till 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Immunology Market – Trends Forecast Till 2030 sales@delvens.comwww.delvens.com

  2. Immunology Market- Trends Forecast Till 2030 Immunology Market, by Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), and Others), by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). Request For Free Sample Report : https://www.delvens.com/get-free-sample/immunology-market-trends-forecast-till-2030 sales@delvens.com www.delvens.com

  3. Market Overview Immunology is a discipline of medical and biological research that studies the immune system. The immune system defends us against infection in a variety of ways. Diseases such as autoimmunity, allergies, and cancer can occur when the human immune system is not operating properly. Autoimmune diseases occur when the immune system attacks the body that it’s meant to protect. People suffering from autoimmune diseases have a defect that makes their immune system unable to distinguish 'self' from ‘non-self’ or 'foreign' molecules. Immunology provides a wide variety of laboratory tests for the detection of autoimmune diseases. The growth of the market can be attributed to various factors such as the Increasing prevalence of autoimmune disorders and increasing product approvals by regulatory agencies. sales@delvens.com www.delvens.com

  4. Market Overview On the other hand, the high costs of immunology drugs, adverse effects associated with these drugs, and lack of awareness are the major factors that can hinder the growth of the global immunology market. The negative effect of the global pandemic, COVID-19, has been felt across several economies facing unprecedented loss, this is owing to the lockdown announced by the government agencies, due to which several industries have been at a standstill with limited operational activities. However, a collective effort from the government and the industries is likely to bring the economy back on track, and aid in the resumption of industrial activities. sales@delvens.com www.delvens.com

  5. MarketSegmentation • Immunology Market is segmented into various segments such as drug class, disease indication, distribution channel, and region: • Based on the distribution channel • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies • Based on region • Asia Pacific • North America • Europe • South America • Middle East & Africa sales@delvens.com www.delvens.com

  6. MarketSegmentation On the basis of the drug class Monoclonal Antibody (mAb) Fusion Proteins Immunosuppressants Polyclonal Antibody (pAb) Based on disease indication Rheumatoid Arthritis Psoriatic Arthritis Plaque Psoriasis Ankylosing Spondylitis Inflammatory Bowel Disease Prophylaxis of Organ Rejection sales@delvens.com www.delvens.com

  7. Competitive Landscape AbbVie Inc. Janssen Global Services Johnson & Johnson F. Hoffmann-La Roche Ltd Amgen Inc. Novartis Astellas Merck Sharp & Dohme Corp. Inquire Before Buying: https://www.delvens.com/Inquire-before-buying/immunology-market-trends-forecast-till-2030 sales@delvens.com www.delvens.com

  8. Recent Developments • August 29, 2022 - AbbVie Showcases New Analyses and Real-World Data Across Multiple Immune-Mediated Skin Diseases at the European Academy of Dermatology and Venereology (EADV). • August 24, 2022 - AbbVie announced that the U.S. Food and Drug Administration (FDA) approved the use of IMBRUVICA® (ibrutinib) for the treatment of pediatric patients one year and older with chronic graft versus host disease (cGVHD) after the failure of one or more lines of systemic therapy. Purchase This Report: https://www.delvens.com/checkout/immunology-market-trends-forecast-till-2030 sales@delvens.com www.delvens.com

  9. Contact Information About Us: Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally. Contact Us: +44-20-8638-5055 sales@delvens.com WEBSITE: https://delvens.com/ sales@delvens.com www.delvens.com

More Related